These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14666675)

  • 21. Local recurrence of breast cancer demonstrated on 99mTc-MIBI scintigraphy.
    Katayama N; Inoue Y; Ichikawa T; Harada M; Itoh T; Shimoyamada K; Ikeda M; Tsukune Y; Yoshikawa K
    Radiat Med; 1999; 17(5):389-91. PubMed ID: 10593293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99mTc-exametazime as a breast tumor-seeking agent: comparison with 99mTc-sestamibi.
    Wilczek B; Svensson L; Danielsson R; Celebiouglu F; Larsson SA; Jacobsson H
    J Nucl Med; 2004 Dec; 45(12):2040-4. PubMed ID: 15585479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 99mTc-MIBI scan in mammary Pagets disease: a case report.
    Han S; Kim JS; Kim BS; Koh IH; Park K
    J Korean Med Sci; 1999 Dec; 14(6):675-8. PubMed ID: 10642948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of occult breast carcinoma during evaluation of a skeletal tumor by Tc-99m MIBI scintigraphy.
    Hod N; Mindlin L; Horne T
    Isr Med Assoc J; 2003 Apr; 5(4):296-7. PubMed ID: 14509141
    [No Abstract]   [Full Text] [Related]  

  • 25. Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors.
    Ballinger JR; Muzzammil T; Moore MJ
    J Nucl Med; 1997 Dec; 38(12):1915-9. PubMed ID: 9430469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An improved syngeneic orthotopic murine model of human breast cancer progression.
    Rashid OM; Nagahashi M; Ramachandran S; Dumur C; Schaum J; Yamada A; Terracina KP; Milstien S; Spiegel S; Takabe K
    Breast Cancer Res Treat; 2014 Oct; 147(3):501-12. PubMed ID: 25200444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
    Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
    Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
    Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
    Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 99mTc-MIBI scintigraphy as an indicator of the chemosensitivity of anthracyclines in patients with breast cancer.
    Fujii H; Nakamura K; Kubo A; Enomoto K; Ikeda T; Kubota T; Matsuzaki SW; Kitajima M
    Anticancer Res; 1998; 18(6B):4601-5. PubMed ID: 9891525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
    Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
    Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
    Belhaj-Tayeb H; Briane D; Vergote J; Kothan S; Léger G; Bendada SE; Tofighi M; Tamgac F; Cao A; Moretti JL
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):502-9. PubMed ID: 12536243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
    Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Sinnett D; Glass DM; Peters AM
    J Nucl Med; 2002 Apr; 43(4):519-25. PubMed ID: 11937596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Mirzaei S; Knoll P; Lipp RW; Köhn H
    J Nucl Med; 2000 Feb; 41(2):390-1. PubMed ID: 10688127
    [No Abstract]   [Full Text] [Related]  

  • 35. Limitation of in vivo models investigating angiogenesis in breast cancer.
    Gehmert S; Gehmert S; Bai X; Klein S; Ortmann O; Prantl L
    Clin Hemorheol Microcirc; 2011; 49(1-4):519-26. PubMed ID: 22214723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
    Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
    J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad.
    Zhang GL; Zhang Y; Cao KX; Wang XM
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The relationship between 99mTc-MIBI scintimammography of breast cancer and multidrug-resistant proteins].
    Cui SD; Liu ZZ; Liu H; Li LF; Yang H; Li WL
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):606-8. PubMed ID: 16438870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
    Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
    Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents.
    Brandt R; Wong AM; Hynes NE
    Oncogene; 2001 Sep; 20(39):5459-65. PubMed ID: 11571643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.